InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.33
(
0.48%
)
Bitcoin
58,253.29
(
-3.17%
)
Post# of 648867
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

matt24d

Send PM Follow Ignore
Followers 398
Posts 86393
Boards Moderated 2
Alias Born 02/05/2004

matt24d

Re: maytepper post# 326047

Thursday, 09/25/2014 12:21:16 PM

Thursday, September 25, 2014 12:21:16 PM

Post# of 648867
RNN here is the part I liked on that read

The company has previously stated that it is engaged in partnering discussions for ‘3117, and we believe that both the data readout from the dose escalation study and the granting of Orphan Designation could potentially catalyze these discussions.”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up